Home

Bafna Pharmaceuticals Ltd PE Ratio

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PE

37.5

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 37.5 as of 22 Feb 15:30 PM .
  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2020 .
  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 71.95 as of 20 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PE

-

Last updated on: Invalid Date

Company Fundamentals for Bafna Pharmaceuticals Ltd

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Share Price

₹ 71.95

3.41 (4.98%)

stock direction

Last updated on: Feb 20, 2025

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 202571.95
18 Feb 202568.54
17 Feb 202571.36
14 Feb 202575
13 Feb 202578.79
12 Feb 202578.79
11 Feb 202575.1
10 Feb 202578.35
05 Feb 202579.36
04 Feb 202579.36

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Bafna Pharmaceuticals Ltd

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Bafna Pharmaceuticals Ltd174.58
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Bafna Pharmaceuticals Ltd Explained

174.58

Market cap

4

Earnings

37.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bafna Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bafna Pharmaceuticals Ltd

No data available

* All values are in %

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Bafna Pharmaceuticals Ltd News Hub

Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter

Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains

Read more

13 Aug 24

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

10 Aug 24

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

04 Sept 24

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on

Read more

05 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bafna Pharmaceuticals Ltd

What is the current PE Ratio of Bafna Pharmaceuticals Ltd?

The Current PE Ratio of Bafna Pharmaceuticals Ltd is 37.46 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Bafna Pharmaceuticals Ltd last year?

The PE Ratio of Bafna Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 37.46, showing a year-on-year growth of -%.

What does the PE Ratio of Bafna Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Bafna Pharmaceuticals Ltd is 37.46. This ratio indicates that investors are willing to pay 37.46 times the earnings per share for each share of Bafna Pharmaceuticals Ltd.

What is the PE Ratio Growth of Bafna Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bafna Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -72.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions